Navigation Links
Reckitt Benckiser Signs Merger Agreement To Acquire Schiff Nutrition
Date:11/21/2012

der in health, hygiene and home, listed on in the top 25 on the London Stock Exchange (LSE).  With a purpose of delivering innovative solutions for healthier lives and happier homes, RB has more trebled revenues since it was formed in 2000 and its market cap has more than quadrupled.  Today it is the global No 1 or No 2 in the majority of its fast-growing categories, driven by an exceptional rate of innovation. Its health, hygiene and home portfolio is led by 19 global Powerbrands including in the over the counter health category Mucinex, Durex, Nurofen, Strepsils Gaviscon and Scholl, and in the hygiene category Lysol, Dettol, Clearasil, Veet, Harpic, Bang, Mortein and Finish. 

RB people and its culture are at the heart of the company's success. They have an intense drive for achievement and a desire to outperform wherever they focus, including in CSR where the company has reduced its carbon footprint by 20% in 5 years and is now targeting to deliver a 1/3 reduction in water use, 1/3 further reduction in carbon and have 1/3 of its net revenue coming from more sustainable products by 2020. It is also the Save the Children charity's largest FMCG global partner.

The company has operations in over 60 countries, with headquarters in the UK, Singapore, Dubai and Amsterdam, and sales in almost 200 countries. The Company employs approximately 38,000 people worldwide.

For more information visit www.rb.com

About Schiff
Schiff's vitamin, minerals and supplements (VMS) product portfolio includes a number of market leading brands in the specialist product category in the USA, including MegaRed®, number 1 in the healthy heart segment, Move Free® the number 2 in joint care, Airborne® the number 2 in immune support, and Schiff Vitamins®.

Forward-Looking Statements
Statements herein regarding the proposed transaction between Reckitt Benckiser and Schiff, future finan
'/>"/>

SOURCE Reckitt Benckiser Group PLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Colorado Telehealth Network Signs Contract with GNAX Health to Provide Statewide Medical Image Archive and Exchange
2. Medisafe 1 Technologies Signs the $7MM Perpetual License Agreement
3. TNI BioTech, Inc. Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC
4. HealthTrust Purchasing Group Signs Renewal for GHX Solutions to Continue Supply Chain Cost Reductions
5. QUANTEL Medical Signs Global Licensing Agreement with IRIDEX
6. PDI Signs Agreement with HealthTrust for Surface Disinfection Products
7. Cincinnati based Radiology Group signs with Comprehensive Medical Practice Management
8. Projecis Signs "Top 5" Worldwide Generic Drug Maker and Niche European CRO as Sales Climb for Software Company
9. Henry Schein Signs Agreement To Expand Animal Health Presence To Ireland With The Acquisition Of C&M Vetlink
10. Parker Signs Licensing Agreement with Vanderbilt for Exoskeleton Technology and Targets Commercial Launch in 2014
11. Varian Medical Systems Signs Purchase Agreement with Advanced Particle Therapy LLC to Supply Technology for the Georgia Proton Treatment Center to be operated by Emory Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- United Medical Education, ... Life Support (ACLS), Pediatric Advanced Life Support (PALS) and ... BLS and ACLS online course manuals. In ... simply need to build an account with the company. ... these programs, United Medical Education is setting a precedent ...
(Date:5/17/2013)... BOSTON , May 17, 2013  TechAtlas ... update for their competitive landscape map for the ... highlights over 90 international companies with drugs and ... addressing CKD and its sequelae. ... include: , hypertension - renal denervation ...
(Date:5/17/2013)... Conn. , May 17, 2013 /PRNewswire-iReach/ -- ... and recombinant proteins, is placing renewed emphasis on ... the rise as a number of factors are ... for pharmaceutical makers and their delivery device partners ... previously refractory conditions, the growing trend toward self-administration ...
Breaking Medicine Technology:ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3
... 11, 2011 Conatus Pharmaceuticals Inc. today announced the ... private placement financing.  This financing was led by new ... participation by existing investors; Aberdare Ventures, Advent Venture Partners, ... Fund.  Conatus will use the proceeds to advance the ...
... 2011 Stryker Corporation,s (NYSE: SYK ) ... 510(k) clearance for its MDM X3 Modular Dual Mobility ... to the company,s portfolio of next-generation technologies designed to ... and address a broader patient population, including both primary ...
Cached Medicine Technology:Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing 2Stryker Receives FDA 510(k) Clearance to Market Modular Dual Mobility Acetabular (Hip) System 2Stryker Receives FDA 510(k) Clearance to Market Modular Dual Mobility Acetabular (Hip) System 3
(Date:5/18/2013)... Adolescents, especially young males, who experiment ... “K2” are landing in emergency rooms across America. ... epidemic with a new treatment program for those ... research from the National Institute on Drug Abuse, synthetic ... American teenagers. In 2012, 11 percent of high school ...
(Date:5/18/2013)... DF (PRWEB) May 18, 2013 The ... leading ayurvedic education institution in the West. Program is ... education. , Ayurveda is a healing modality practiced for ... ), it is considered that health begins when an ... profound understanding of their individual needs. Ayurveda aims to ...
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 Rio ... has recently completed a stylish renovation that features tranquil, ... specialties. , From the ground up, this Morro ... with fresh flooring, soothing colors and comfortable spa beds. ... installed, including an Apilus epilator machine. The shampoo ...
(Date:5/18/2013)... 2013 Losing weight remains to be the ... horde of new weight loss products available in the market ... studies about this newest weight loss supplement prove that dieting ... , Garcinia Cambogia is a sub-tropical fruit that is shaped ... fruit can suppress a person’s appetite, while it effectively burns ...
(Date:5/18/2013)... 2013 Spectrum Surgical Instruments will ... 17-22 in Austin, TX where thousands of GI ... networking opportunities. , Spectrum Surgical/STERIS will feature ... repair capabilities and certified pre-owned equipment. Attendees ... on proper instrument care of flexible endoscopes. ...
Breaking Medicine News(10 mins):Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2
... Feb. 11 Abbott ( NYSE: ABT ),today ... Food and Drug,Administration (FDA) for its new, compact ... expand the company,s hematology,platform by offering a high ... laboratories. , As small ...
... Inc., a privately held company located in the Midwest, ... eliminates all of the most common problems associated with ... therapy hasn,t always been therapeutic for many people. The ... never continue therapy beyond the first night ... because ...
... Tibotec Therapeutics, a division of Centocor Ortho ... a lower-dose (75 mg) formulation of PREZISTA (darunavir) ... the FDA approval of PREZISTA, co-administered with ritonavir ... treatment of HIV infection in pediatric patients six ...
... Men, Women Differ in Oral Health Care Habits , CHICAGO, ... what do people find most attractive in others? The smile. ... Crest(R) and Oral B(R) finds that the smile outranked eyes, ... men and women differ when it comes to taking care ...
... Ongoing Study Shows Seven of 14 Evaluable Patients ... Two Treatment Cycles----Bavituximab Has Now Produced Positive Early ... Therapy Cancer Trials--TUSTIN, Calif., Feb. 11 Peregrine ... reported that its lead product candidate bavituximab achieved ...
... Sanofi-aventis announced today that Jean-Pierre ... Chief Medical Officer (CMO). He was previously Senior ... Marc Cluzel, Senior Vice President, Research & Development, who ... Officer is a further demonstration internally and externally of ...
Cached Medicine News:Health News:Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument 2Health News:Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument 3Health News:Husband From Small Town May Have Found Solution to Sleep Industry's 20-Year Compliance Problem 2Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 2Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 3Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 4Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 5Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 6Health News:PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy 7Health News:Survey Finds Smile is 'Most Attractive' Physical Feature 2Health News:Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study 2Health News:Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study 3Health News:Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study 4Health News:Jean-Pierre Lehner Appointed Chief Medical Officer 2
...
Solid blade speculum designed for both temporal and superior approach ocular surgery. Adjustable with thumb screw. Manufactured in titanium....
Adjustable lid speculum angled 45 degrees with 17 mm curved solid blades and aspiration ports to remove excess fluid from around the eye during ocular procedures....
Adjustable lid speculum with mm blades. Miniature frame ideal for deep set eyes and small orbital structures....
Medicine Products: